Latest developments: 38 companies have publicly opposed the OKX-ICE tokenized stock plan, including Walmart and Eli Lilly. Disclosed information shows that the opposing parties include traditional giants, and the dispute centers on third-party stock tokenization. The plan has encountered public opposition at the issuer level, and the authorization basis and compliance path for stock tokenization have become focal points. Because the matter involves both SEC exemption rules and the issuer authorization dispute, its market impact and future scalability are drawing attention.
Key facts: Currently confirmable information includes: the OKX-ICE tokenized stock plan; 38 companies opposing the plan; Walmart and Eli Lilly among the opposing companies; the opposing side comprising traditional giants; the dispute centering on third-party stock tokenization; and the matter involving SEC exemption rules and issuer authorization. The appearance of Walmart and Eli Lilly on the opposition list further clarifies the corporate composition of the opposing parties. Available information does not disclose the specific manner of the 38 companies' opposition, the full list, the text of their demands, or the specific terms of the plan, the SEC's response, and follow-up arrangements. These information boundaries mean that current discussion should focus on confirmed facts rather than inferences about undisclosed details.
Dispute focus: issuer authorization and SEC exemption rules. Third-party stock tokenization requires handling the rights relationship between issuers and tokenization platforms. The source material lists the issuer authorization dispute as one of the core issues, and opposition from 38 companies has brought this issue into the open. For traditional companies, whether their shares have been authorized for third-party tokenization and how the scope of authorization is defined are key questions in the matter. The current material does not state whether the opposing companies have raised specific authorization requirements, nor whether OKX-ICE has obtained relevant authorization, so market attention is concentrated on the issuer authorization dispute itself. At the same time, the plan involves SEC exemption rules, and compliance arrangements are linked to the application of regulatory exemptions. Available material does not disclose the specific provisions of the exemption rules, applicable conditions, application status, or regulatory response, nor whether the opposing companies have raised objections to the exemption rules. What can be confirmed is that the matter has simultaneously touched two lines: issuer authorization and regulatory exemption. For stock tokenization, these concern the compliance basis and source of rights, rather than simply the launch of a single product. Regulatory exemption and issuer authorization together constitute the two dispute lines in current public information. If relevant parties make further disclosures, the focus of the dispute may become more specific.
Scope of impact: The opposition of 38 companies, including Walmart and Eli Lilly, shows that traditional companies' attitude toward third-party stock tokenization is not an isolated case. The source material describes the event as having large market impact and strong future scalability because it involves the combination of traditional stock assets with tokenization platforms, as well as the application of issuer authorization and SEC exemption rules. Current information is insufficient to determine whether the plan will be adjusted or terminated, but it can be confirmed that the opposition of 38 companies has publicized the plan's compliance dispute and raised market attention to authorization issues in stock tokenization. The main news point of the event is the authorization and compliance conflict between traditional listed companies and tokenization platforms, rather than the technical details of the tokenized stock plan itself.
Information boundaries: Currently available public material does not provide the full list of the 38 opposing companies, the content of the opposition letters, OKX-ICE's formal response, the SEC's position, or the plan timetable. Therefore, judgments about the event's subsequent impact still require more factual disclosure. Confirmed information centers on the number of opposing parties, some company names, the subject of the dispute, and the connection to regulatory rules. The core facts at the news level are: traditional giants have publicly opposed third-party stock tokenization, and the dispute involves SEC exemption rules and issuer authorization. The event has attracted attention because it simultaneously touches the boundaries of traditional stock issuers' rights and the product compliance path of relevant platforms. In the absence of formal responses and regulatory documents, discussion of the event's subsequent impact should remain at the level of disclosed facts.
Follow-up: Going forward, attention may be paid to whether OKX-ICE responds to the objections or adjusts the tokenized stock plan; whether the 38 companies take further action; whether the application of SEC exemption rules in third-party stock tokenization is clarified; and whether the issuer authorization dispute can form an executable resolution path. All these directions should be subject to regulatory documents, company statements, or disclosures by the plan sponsor. At the current stage, the event remains at the stage of public opposition from traditional giants and escalating compliance controversy, and market impact and future scalability await confirmation by more facts. The above follow-up directions only represent trackable disclosure leads and do not represent predictions of the event's outcome.